Coronavirus
Commentary
Fauci Has Only Himself to Blame for His COVID Legacy
“We have seen complete fabrications become some people’s accepted reality,” Dr. Anthony Fauci laments in his new memoir “On Call: A Doctor’s Journey in Public Service.” Surely the good doctor means to speak about his ideological foes, who have long decried the heavy-handed response to COVID-19 that Dr. Fauci symbolizes. But today, ...
Sally C. Pipes
July 23, 2024
Commentary
Read the latest on drug pricing
Cost-Based Pricing For Innovative Medicines Is Unviable And Harmful
Barber et al. just published a fundamentally flawed study on diabetes medicines in JAMA Network Open (JNO). This study wrongly suggests that cost-based pricing accurately values innovative on-patent medicines, distracts from serious policymaking, and fuels political grandstanding by politicians such as Senator Bernie Sanders. Cost-based pricing could be an economically viable pricing ...
Wayne Winegarden
April 12, 2024
Coronavirus
NEW BRIEF: Regulatory Roadblocks Hinder Development of New COVID-19 Treatments for the Immunocompromised
The current federal regulatory process to develop monoclonal antibodies to treat mutating strains of COVID-19 imposes unnecessary hurdles that hinder the creation and approval of effective treatments for the immunocompromised, finds a new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute. ...
Wayne H Winegarden
March 6, 2024
Commentary
Why weakening of intellectual property rules is a threat to California
This week, members of the World Trade Organization have convened half a world away in Abu Dhabi. But a proposal on the agenda could have profound consequences for us here in California. Representatives of the World Trade Organization’s 164 member nations will discuss whether to waive patent protections on COVID-19 ...
Sally C. Pipes
February 26, 2024
Commentary
This Policy Helped Make COVID Vaccines Possible. It Could Soon Disappear.
If you’re among the 81% of Americans who have been vaccinated against COVID-19, you probably remember your first dose. Perhaps you snapped a selfie on your way out of the vaccine clinic. California Sen. Alex Padilla took things a step further and shared a video on Facebook encouraging his constituents to get the jab. ...
Sally C. Pipes
February 5, 2024
Coronavirus
PRI Covid Tradeoffs Brief Receives National Coverage
PRI Brief on Tradeoffs from COVID-19 Restrictions Featured in National Review
Economist Wayne Winegarden and policy associate McKenzie Richards of the nonpartisan, pro-free-market Pacific Research Institute recently authored a research brief detailing how more-severe Covid-19 mitigation policies — namely lockdowns, masking mandates, school and business closures, and social distancing — led to reduced infection and mortality rates, but at the expense of ...
Pacific Research Institute
October 25, 2023
Commentary
Improving The FDA’s Regulatory Process Can Enhance Treatment Options
Peter Marks, director of Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research noted that “vaccination remains critical to public health and continued protection against serious consequences of Covid-19, including hospitalization and death.” But what is the protection for those Americans who can’t take the vaccine? Read the ...
Wayne Winegarden
October 16, 2023
Coronavirus
NEW BRIEF: COVID-19 Restrictions Led to Small Health Benefits Negated by Tradeoff of Huge Economic, Education Losses
States that had more invasive COVID-19 restrictions saw small reductions in COVID-19 infection and mortality rates, but saw large negative impacts on employment, economic growth, and children’s education outcomes, finds a new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute.CMEI_Covid_FINAL Click ...
Pacific Research Institute
September 26, 2023
Commentary
Nation Past COVID Emergency, Medicaid Needs to Do the Same
With the expiration of the COVID-19 public health emergency, states are finally able to remove people from Medicaid who are not eligible for the program under the law. Some are taking full advantage. A recent analysis by the Kaiser Family Foundation found that at least 565,000 patients in 12 states have been ...
Sally C. Pipes
June 14, 2023
Commentary
Moderna, Pfizer signal they plan to raise price of their shots
In defense of pandemic profits
The price of a COVID-19 shot will soon go up. The federal public health emergency ended this month, and the government will stop providing COVID vaccines to all Americans free of charge. Moderna and Pfizer have both signaled that they plan to raise the prices of their shots once the ...
Sally C. Pipes
May 21, 2023
Fauci Has Only Himself to Blame for His COVID Legacy
“We have seen complete fabrications become some people’s accepted reality,” Dr. Anthony Fauci laments in his new memoir “On Call: A Doctor’s Journey in Public Service.” Surely the good doctor means to speak about his ideological foes, who have long decried the heavy-handed response to COVID-19 that Dr. Fauci symbolizes. But today, ...
Read the latest on drug pricing
Cost-Based Pricing For Innovative Medicines Is Unviable And Harmful
Barber et al. just published a fundamentally flawed study on diabetes medicines in JAMA Network Open (JNO). This study wrongly suggests that cost-based pricing accurately values innovative on-patent medicines, distracts from serious policymaking, and fuels political grandstanding by politicians such as Senator Bernie Sanders. Cost-based pricing could be an economically viable pricing ...
NEW BRIEF: Regulatory Roadblocks Hinder Development of New COVID-19 Treatments for the Immunocompromised
The current federal regulatory process to develop monoclonal antibodies to treat mutating strains of COVID-19 imposes unnecessary hurdles that hinder the creation and approval of effective treatments for the immunocompromised, finds a new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute. ...
Why weakening of intellectual property rules is a threat to California
This week, members of the World Trade Organization have convened half a world away in Abu Dhabi. But a proposal on the agenda could have profound consequences for us here in California. Representatives of the World Trade Organization’s 164 member nations will discuss whether to waive patent protections on COVID-19 ...
This Policy Helped Make COVID Vaccines Possible. It Could Soon Disappear.
If you’re among the 81% of Americans who have been vaccinated against COVID-19, you probably remember your first dose. Perhaps you snapped a selfie on your way out of the vaccine clinic. California Sen. Alex Padilla took things a step further and shared a video on Facebook encouraging his constituents to get the jab. ...
PRI Covid Tradeoffs Brief Receives National Coverage
PRI Brief on Tradeoffs from COVID-19 Restrictions Featured in National Review
Economist Wayne Winegarden and policy associate McKenzie Richards of the nonpartisan, pro-free-market Pacific Research Institute recently authored a research brief detailing how more-severe Covid-19 mitigation policies — namely lockdowns, masking mandates, school and business closures, and social distancing — led to reduced infection and mortality rates, but at the expense of ...
Improving The FDA’s Regulatory Process Can Enhance Treatment Options
Peter Marks, director of Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research noted that “vaccination remains critical to public health and continued protection against serious consequences of Covid-19, including hospitalization and death.” But what is the protection for those Americans who can’t take the vaccine? Read the ...
NEW BRIEF: COVID-19 Restrictions Led to Small Health Benefits Negated by Tradeoff of Huge Economic, Education Losses
States that had more invasive COVID-19 restrictions saw small reductions in COVID-19 infection and mortality rates, but saw large negative impacts on employment, economic growth, and children’s education outcomes, finds a new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute.CMEI_Covid_FINAL Click ...
Nation Past COVID Emergency, Medicaid Needs to Do the Same
With the expiration of the COVID-19 public health emergency, states are finally able to remove people from Medicaid who are not eligible for the program under the law. Some are taking full advantage. A recent analysis by the Kaiser Family Foundation found that at least 565,000 patients in 12 states have been ...
Moderna, Pfizer signal they plan to raise price of their shots
In defense of pandemic profits
The price of a COVID-19 shot will soon go up. The federal public health emergency ended this month, and the government will stop providing COVID vaccines to all Americans free of charge. Moderna and Pfizer have both signaled that they plan to raise the prices of their shots once the ...